LDS/Medical Tests/Adenosine Deaminase, Body Fluid

Adenosine Deaminase, Body Fluid

Adenosine Deaminase (also known as adenosine aminohydrolase, or ADA) is an enzyme involved in purine metabolism and its main role is in the development and maintenance of the immune system. ADA is produced by cells throughout the body and is also associated with the activation of lymphocytes. It can be used as adjunctive evidence in support of a diagnosis of infection by Mycobacterium tuberculosis. It is used mostly to test pleural fluid as an adjunct test to help rule in or rule out tuberculosis in pleural fluid. Rarely, it may be ordered to detect tuberculosis in other body fluids, such as peritoneal fluid or cerebrospinal fluid (CSF). Increased levels of ADA are supportive of a diagnosis of infection by Mycobacterium tuberculosis.

Mutation in the ADA gene results in an autosomal recessive disorder of purine metabolism known as Adenosine Deaminase Deficiency, also known as Severe Combined Immunodeficiency (SCID), primarily affecting lymphocyte development, viability and function. Increased levels of plasma ADA have been observed in some autoimmune diseases such as rheumatoid arthritis, psoriasis and sarcoidosis. The plasma ADA2 isoform is also increased in most cancers.

  • As an aid in diagnosis of tuberculosis
  • As an aid in diagnosis of severe combined immunodeficiency (SCID)
  • As an aid in diagnosis of rheumatoid arthritis

Increased in:

  • Tuberculosis
  • Rheumatoid arthritis
  • Psoriasis
  • Sarcoidosis
  • Typhoid
  • Infectious mononucleosis Certain malignancies
  • Liver disease

Decreased in:  

  • Deficiency is seen in an autosomal recessive genetic disorder. In approximately 90 percent of cases, it leads to a severe combined immunodeficiency (ADA-SCID) with dysfunction of T, B and natural killer (NK) cells (T-B-NK- SCID). This presents in the first few months of life. A lack of adenosine deaminase (ADA) allows deoxyadenosine to accumulate and kill lymphocytes.
  • A person with a low ADA level is unlikely to have tuberculosis in their pleurae. This does not rule out having the infection in other parts of their body. If ADA is markedly elevated in fluid from another part of the body, such as peritoneal fluid or CSF, then there is an increased likelihood that tuberculosis is present in another area of the body.

For ADA-SCID: for RBC the range is 400-900 mU/g Hb

Spectrophotometry (Kinetic)

Body fluid collected in sterile container. 

Stability

  • Ambient: 2-5 days
  • Refrigerated: 7-14 days
Acid-Fast Bacillus (AFB) Stain, Mycobacterial Culture, Mycobacterium tuberculosis Complex, Molecular Detection, PCR, Mycobacterial Species by Molecular Detection, HIV.
1-3 days
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login